Otsuka Holdings Co., Ltd. Logo

Otsuka Holdings Co., Ltd.

Global healthcare group creating pharmaceuticals and nutraceuticals for worldwide well-being.

4578 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
千代田区神田司町2−9
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Otsuka Holdings Co., Ltd. is a global healthcare group operating under the corporate philosophy of 'Otsuka-people creating new products for better health worldwide.' The company's operations are centered around two core segments: the Pharmaceutical Business and the Nutraceutical Business. The Pharmaceutical division focuses on the research, development, manufacturing, and sale of innovative products for the diagnosis and treatment of diseases, with a strong presence in areas such as central nervous system disorders, oncology, and cardiovascular diseases. The Nutraceutical division provides products that support daily health maintenance and improvement, including functional foods and beverages like POCARI SWEAT and SOYJOY, as well as 'Cosmedics' (cosmetics + medicine). The group is committed to a holistic approach to health, creating highly original products to contribute to the well-being of people globally.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Otsuka Holdings Co., Ltd. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-07-31 09:22
Regulatory News Service
確認書
Japanese 8.3 KB
2025-07-31 09:21
Interim Report
半期報告書-第18期(2025/01/01-2025/12/31)
Japanese 340.0 KB
2025-05-22 03:58
Regulatory News Service
発行登録追補書類(株券、社債券等)
Japanese 101.5 KB
2025-05-12 06:10
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 26.1 KB
2025-05-08 09:07
Prospectus
発行登録書(株券、社債券等)
Japanese 26.0 KB
2025-05-07 09:48
Regulatory News Service
臨時報告書
Japanese 21.0 KB
2025-05-02 09:29
Regulatory News Service
訂正臨時報告書
Japanese 29.3 KB
2025-04-14 09:03
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 22.6 KB
2025-04-01 09:00
Regulatory News Service
臨時報告書
Japanese 25.5 KB
2025-04-01 09:00
Regulatory News Service
臨時報告書
Japanese 41.6 KB
2025-03-31 04:06
Regulatory News Service
確認書
Japanese 8.3 KB
2025-03-31 04:05
Regulatory News Service
内部統制報告書-第17期(2024/01/01-2024/12/31)
Japanese 23.9 KB
2025-03-31 04:04
Annual Report
有価証券報告書-第17期(2024/01/01-2024/12/31)
Japanese 3.3 MB
2025-03-21 08:16
Regulatory News Service
臨時報告書
Japanese 20.7 KB
2025-03-14 08:09
Regulatory News Service
訂正臨時報告書
Japanese 26.2 KB

Automate Your Workflow. Get a real-time feed of all Otsuka Holdings Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Otsuka Holdings Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Can-Fite BioPharma Ltd. Logo
Develops oral small-molecule drugs targeting A3AR for oncology and inflammatory diseases.
Israel CANF
Cannovum Cannabis AG Logo
Importer & producer of medical cannabis, expanding into recreational cultivation infrastructure.
Germany 27N0
Cantourage Group SE Logo
A European platform producing and distributing medical cannabis products to pharmacies.
Germany HIGH
CAREGEN CO.,LTD. Logo
Develops patented peptides and growth factors for medical aesthetics, pharma, and anti-aging markets.
South Korea 214370
CELADON PHARMACEUTICALS PLC Logo
Vertically integrated pharma developing cannabis medicines for chronic pain.
United Kingdom CEL
Celemics, Inc. Logo
Develops custom NGS panels and bioinformatics for research and clinical diagnostics.
South Korea 331920
Develops & manufactures radiopharmaceuticals for cancer diagnosis and therapy.
South Korea 308430
CELL BIOTECH CO ., LTD Logo
A global biotech firm offering probiotic raw materials, OEM/ODM services, and consumer brands.
South Korea 049960
Cellectis Logo
Develops 'off-the-shelf' CAR T-cell cancer immunotherapies using TALEN® gene-editing.
France ALCLS
Cellid Co., Ltd. Logo
Biotech firm developing proprietary vaccine platforms for cancer and infectious diseases.
South Korea 299660

Talk to a Data Expert

Have a question? We'll get back to you promptly.